The North America CRISPR and Cas Gene is witnessing robust growth owing to increasing investments in biotechnology research, expanding applications of gene-editing technologies, and supportive regulatory initiatives. The region benefits from well-established healthcare infrastructure, high research and development spending, and strong collaboration among pharmaceutical companies, research...